Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

Summary

Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl peroxide 3.75% gel. This study is designed to evaluate the safety and efficacy of this formulation in subjects with Acne Vulgaris

Timeline

Start

2015-05

Primary completion

2015-10

Completion

2015-11

Outcome

Met primary endpoint

registry analysis (superiority test); Generic Clindamycin and Benzoyl Peroxide; p = 0.0001; ANOVA NCT02616614 ↗

registry analysis (superiority test); Generic Clindamycin and Benzoyl Peroxide; p = 0.0002; ANOVA NCT02616614 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Clindamycin/benzoyl peroxide	Unknown	1.2 %	Topical
Subject	Clindamycin/benzoyl peroxide	Unknown	3.75 %	Topical

Indications